Drug Shortage Report for CABAZITAXEL FOR INJECTION
| Report ID | 203175 |
| Drug Identification Number | 02487497 |
| Brand name | CABAZITAXEL FOR INJECTION |
| Common or Proper name | CABAZITAXEL |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | CABAZITAXEL |
| Strength(s) | 45MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 4.5ML |
| ATC code | L01CD |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2023-08-29 |
| Estimated end date | 2023-11-17 |
| Actual end date | 2023-11-20 |
| Shortage status | Resolved |
| Updated date | 2023-11-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2023-11-21 | English | Compare |
| v10 | 2023-11-20 | French | Compare |
| v9 | 2023-11-20 | English | Compare |
| v8 | 2023-10-30 | French | Compare |
| v7 | 2023-10-30 | English | Compare |
| v6 | 2023-10-16 | French | Compare |
| v5 | 2023-10-16 | English | Compare |
| v4 | 2023-08-30 | English | Compare |
| v3 | 2023-08-29 | French | Compare |
| v2 | 2023-08-29 | English | Compare |
| v1 | 2023-08-29 | English | Compare |
Showing 1 to 11 of 11